Metastatic Prostate Neuroendocrine Carcinoma

specific

A neuroendocrine carcinoma that arises from the prostate gland and has spread to other anatomic sites.

39

Centers

50

Active Trials

$8.6B

Cancer Funding

Top Centers for Metastatic Prostate Neuroendocrine Carcinoma(39)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
57.1
2
NCI Comprehensive
Active Research Program
57.1
357.1
4
NCI Comprehensive
Active Research Program
57.1
5
NCI Comprehensive
Active Research Program
57.1
6
NCI Comprehensive
Active Research Program
57.1
7
Active Research Program
57.1
8
NCI Comprehensive
9
NCI Comprehensive
10
NCI Comprehensive
11
NCI Comprehensive
12
NCI Comprehensive
13
NCI Comprehensive
14
NCI Comprehensive
15
16
NCI Comprehensive
17
18
19
NCI Comprehensive
20
NCI Comprehensive
21
NCI Comprehensive
22
NCI Comprehensive
23
24
NCI Comprehensive
25
NCI Comprehensive
26
27
28
NCI Comprehensive
29
30
31
32
33
34
35
36
37
38
39

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →